Psychology and Education Sciences, University of Geneva, Switzerland.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Transl Vis Sci Technol. 2023 Mar 1;12(3):1. doi: 10.1167/tvst.12.3.1.
To describe two new stereoacuity tests: the eRDS v6 stereotest, a global dynamic random dot stereogram (dRDS) test, and the Vivid Vision Stereo Test version 2 (VV), a local or "contour" stereotest for virtual reality (VR) headsets; and to evaluate the tests' reliability, validity compared to a dRDS standard, and learning effects.
Sixty-four subjects passed a battery of stereotests, including perceiving depth from RDS. Validity was evaluated relative to a tablet-based dRDS reference test, ASTEROID. Reliability and learning effects were assessed over six sessions.
eRDS v6 was effective at measuring small thresholds (<10 arcsec) and had a moderate correlation (0.48) with ASTEROID. Across the six sessions, test-retest reliability was good, varying from 0.84 to 0.91, but learning occurred across the first three sessions. VV did not measure stereoacuities below 15 arcsec. It had a weak correlation with ASTEROID (0.27), and test-retest reliability was poor to moderate, varying from 0.35 to 0.74; however, no learning occurred between sessions.
eRDS v6 is precise and reliable but shows learning effects. If repeated three times at baseline, this test is well suited as an outcome measure for testing interventions. VV is less precise, but it is easy and rapid and shows no learning. It may be useful for testing interventions in patients who have no global stereopsis.
eRDS v6 is well suited as an outcome measure to evaluate treatments that improve adult stereodepth perception. VV can be considered for screening patient with compromised stereovision.
描述两种新的立体视锐度测试:eRDS v6 立体测试,一种全局动态随机点立体图(dRDS)测试,以及 Vivid Vision Stereo Test version 2(VV),一种用于虚拟现实(VR)头显的局部或“轮廓”立体测试;并评估这些测试的可靠性、与 dRDS 标准的有效性以及学习效果。
64 名受试者通过了一系列立体测试,包括从 RDS 感知深度。有效性是相对于基于平板电脑的 dRDS 参考测试 ASTEROID 进行评估的。可靠性和学习效果在六次测试中进行了评估。
eRDS v6 能够有效测量小阈值(<10 弧秒),与 ASTEROID 具有中度相关性(0.48)。在六次测试中,测试-重测可靠性良好,范围从 0.84 到 0.91,但在前三次测试中存在学习效应。VV 无法测量 15 弧秒以下的立体视锐度。它与 ASTEROID 的相关性较弱(0.27),测试-重测可靠性较差到中等,范围从 0.35 到 0.74;然而,在测试之间没有学习效应。
eRDS v6 精确且可靠,但存在学习效应。如果在基线时重复进行三次,该测试非常适合作为测试干预措施的结果测量。VV 不太精确,但它简单快速,且不存在学习效应。对于测试那些没有全局立体视的患者的干预措施,它可能是有用的。
本文是一篇医学研究论文,专业术语较多,因此翻译时需要特别注意,保证译文的准确性和专业性。